Clinical Care Considerations: Clinical Considerations for Care of Children and Adults with Confirmed COVID-19: Reinfection

Details

• Alternative Title:
  Reinfection
• Corporate Authors:
  National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
• Description:
  Updated May 27, 2022
  
  Studies suggest that reinfection with SARS-CoV-2 with the same virus variant as the initial infection or reinfection with a different variant are both possible; early reinfection within 90 days of the initial infection can occur.(99-101) Symptoms during reinfection are likely to be less severe than during the initial infection, but some people can experience more severe COVID-19 during reinfection.(99,100,102,103) Both previous infection and vaccination have been shown to provide some protection against infection, although risk of reinfection varies by circulating variant(104-107) Although rates of reinfection might change as new variants emerge, vaccination remains the safest strategy for preventing future SARS-CoV-2 infections, hospitalizations, long-term sequelae, and death. Staying up to date on primary vaccination, additional doses, and booster doses, is recommended for all eligible persons. Strategies to diagnose and treat reinfection are no different than those used to diagnose and treat initial COVID-19 infection; early testing, isolation, and treatment as indicated are recommended for all people who experience symptoms of COVID-19.
  
  
• Subjects:
  Child Child Health Services COVID-19 Reinfection SARS-CoV-2
• Series:
  Clinical Care Considerations
• Document Type:
  Text
• Collection(s):
  Stephen B. Thacker CDC Library
• Main Document Checksum:
  urn:sha-512:fa4bd043f5a72f129219d998b884a52452ca0ffc85cc2499c9e2d82a93e54e86d7a20619d17cfbfa90e1ff8b1b8f0da4dde4336fad506f4e84819a3e21501d98
• Download URL:
  https://stacks.cdc.gov/view/cdc/117886/cdc_117886_DS1.pdf
• File Type:
  [PDF - 267.77 KB ]